Literature DB >> 26100496

Inhibition of sterile danger signals, uric acid and ATP, prevents inflammasome activation and protects from alcoholic steatohepatitis in mice.

Arvin Iracheta-Vellve1, Jan Petrasek1, Abhishek Satishchandran1, Benedek Gyongyosi1, Banishree Saha1, Karen Kodys1, Katherine A Fitzgerald1, Evelyn A Kurt-Jones1, Gyongyi Szabo2.   

Abstract

BACKGROUND & AIMS: The inflammasome is a well-characterized inducer of inflammation in alcoholic steatohepatitis (ASH). Inflammasome activation requires two signals for mature interleukin (IL)-1β production. Here we asked whether metabolic danger signals trigger inflammasome activation in ASH.
METHODS: Wild-type mice, ATP receptor 2x7 (P2rx7)-KO mice, or mice overexpressing uricase were fed Lieber-DeCarli ethanol or control diet. We also implemented a pharmacological approach in which mice were treated with probenecid or allopurinol.
RESULTS: The sterile danger signals, ATP and uric acid, were increased in the serum and liver of alcohol-fed mice. Depletion of uric acid or ATP, or lack of ATP signaling attenuated ASH and prevented inflammasome activation and its major downstream cytokine, IL-1β. Pharmacological depletion of uric acid with allopurinol provided significant protection from alcohol-induced inflammatory response, steatosis and liver damage, and additional protection was achieved in mice treated with probenecid, which depletes uric acid and blocks ATP-induced P2rx7 signaling. We found that alcohol-damaged hepatocytes released uric acid and ATP in vivo and in vitro and that these sterile danger signals activated the inflammasome in LPS-exposed liver mononuclear cells.
CONCLUSIONS: Our data indicate that the second signal in inflammasome activation and IL-1β production in ASH results from the endogenous danger signals, uric acid and ATP. Inhibition of signaling triggered by uric acid and ATP may have therapeutic implications in ASH.
Copyright © 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alcoholic steatohepatitis; Damage-associated molecular patterns; Determinants of liver inflammation; Inflammasome; Pathogen-associated molecular patterns; Sterile inflammatory response

Mesh:

Substances:

Year:  2015        PMID: 26100496      PMCID: PMC4615393          DOI: 10.1016/j.jhep.2015.06.013

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  30 in total

1.  Interrelation of uric acid and ethanol metabolism in man.

Authors:  C S LIEBER; D P JONES; M S LOSOWSKY; C S DAVIDSON
Journal:  J Clin Invest       Date:  1962-10       Impact factor: 14.808

Review 2.  The inflammasomes.

Authors:  Kate Schroder; Jurg Tschopp
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

3.  The pannexin 1 channel activates the inflammasome in neurons and astrocytes.

Authors:  William R Silverman; Juan Pablo de Rivero Vaccari; Silviu Locovei; Feng Qiu; Steven K Carlsson; Eliana Scemes; Robert W Keane; Gerhard Dahl
Journal:  J Biol Chem       Date:  2009-05-05       Impact factor: 5.157

Review 4.  Alcoholic liver disease.

Authors:  Robert S O'Shea; Srinivasan Dasarathy; Arthur J McCullough
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

5.  Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study.

Authors:  Youming Li; Chengfu Xu; Chaohui Yu; Lei Xu; Min Miao
Journal:  J Hepatol       Date:  2009-01-09       Impact factor: 25.083

Review 6.  Immune tolerance: what is unique about the liver.

Authors:  Gisa Tiegs; Ansgar W Lohse
Journal:  J Autoimmun       Date:  2009-08-29       Impact factor: 7.094

7.  Effects of allopurinol on ischemia and reperfusion in rabbit livers.

Authors:  M O Taha; M J Simões; E C Noguerol; F P Mendonça; H M A Pascoalick; R A M Alves; M E M Vivian; F P Morales; A C A Campos; K G Magalhães; P S Venerando; I L S Tersariol; H P Monteiro; I S Oliveira-Júnior; I Oliveira; A Jurkiewicz; A Caricati-Neto
Journal:  Transplant Proc       Date:  2009-04       Impact factor: 1.066

Review 8.  The NLRP3 inflammasome: a sensor for metabolic danger?

Authors:  Kate Schroder; Rongbin Zhou; Jurg Tschopp
Journal:  Science       Date:  2010-01-15       Impact factor: 47.728

9.  Role of hepatocytes in direct clearance of lipopolysaccharide in rats.

Authors:  Y Mimura; S Sakisaka; M Harada; M Sata; K Tanikawa
Journal:  Gastroenterology       Date:  1995-12       Impact factor: 22.682

Review 10.  Immunological and inflammatory functions of the interleukin-1 family.

Authors:  Charles A Dinarello
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

View more
  41 in total

Review 1.  The contrasting roles of inflammasomes in cancer.

Authors:  Qin He; Yu Fu; Dean Tian; Wei Yan
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

2.  Interleukin-1 inhibition facilitates recovery from liver injury and promotes regeneration of hepatocytes in alcoholic hepatitis in mice.

Authors:  Arvin Iracheta-Vellve; Jan Petrasek; Benedek Gyogyosi; Shashi Bala; Timea Csak; Karen Kodys; Gyongyi Szabo
Journal:  Liver Int       Date:  2017-04-27       Impact factor: 5.828

Review 3.  A Unifying Hypothesis Linking Hepatic Adaptations for Ethanol Metabolism to the Proinflammatory and Profibrotic Events of Alcoholic Liver Disease.

Authors:  Zhi Zhong; John J Lemasters
Journal:  Alcohol Clin Exp Res       Date:  2018-09-17       Impact factor: 3.455

4.  Alcohol abuse is associated with enhanced pulmonary and systemic xanthine oxidoreductase activity.

Authors:  Mehdi A Fini; Jeanette Gaydos; Alicia McNally; Vijaya Karoor; Ellen L Burnham
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-24       Impact factor: 5.464

5.  Endoplasmic Reticulum Stress-induced Hepatocellular Death Pathways Mediate Liver Injury and Fibrosis via Stimulator of Interferon Genes.

Authors:  Arvin Iracheta-Vellve; Jan Petrasek; Benedek Gyongyosi; Abhishek Satishchandran; Patrick Lowe; Karen Kodys; Donna Catalano; Charles D Calenda; Evelyn A Kurt-Jones; Katherine A Fitzgerald; Gyongyi Szabo
Journal:  J Biol Chem       Date:  2016-11-03       Impact factor: 5.157

6.  Pharmacological Inhibition of CCR2/5 Signaling Prevents and Reverses Alcohol-Induced Liver Damage, Steatosis, and Inflammation in Mice.

Authors:  Aditya Ambade; Patrick Lowe; Karen Kodys; Donna Catalano; Benedek Gyongyosi; Yeonhee Cho; Arvin Iracheta-Vellve; Adeyinka Adejumo; Banishree Saha; Charles Calenda; Jeeval Mehta; Eric Lefebvre; Pamela Vig; Gyongyi Szabo
Journal:  Hepatology       Date:  2019-02-12       Impact factor: 17.425

Review 7.  Alcoholic liver disease.

Authors:  Helmut K Seitz; Ramon Bataller; Helena Cortez-Pinto; Bin Gao; Antoni Gual; Carolin Lackner; Philippe Mathurin; Sebastian Mueller; Gyongyi Szabo; Hidekazu Tsukamoto
Journal:  Nat Rev Dis Primers       Date:  2018-08-16       Impact factor: 52.329

8.  Association of the serum uric acid level with liver histology in biopsy-proven non-alcoholic fatty liver disease.

Authors:  Qian Huang; Jianhua Yu; Xiantu Zhang; Shourong Liu; Yanyan Ge
Journal:  Biomed Rep       Date:  2016-06-01

9.  Liver kinase B1/AMP-activated protein kinase-mediated regulation by gentiopicroside ameliorates P2X7 receptor-dependent alcoholic hepatosteatosis.

Authors:  Xia Li; Yu Zhang; Quan Jin; Kai-Li Xia; Min Jiang; Ben-Wen Cui; Yan-Ling Wu; Shun-Zong Song; Li-Hua Lian; Ji-Xing Nan
Journal:  Br J Pharmacol       Date:  2018-03-09       Impact factor: 8.739

Review 10.  Role of MicroRNAs in NAFLD/NASH.

Authors:  Gyongyi Szabo; Timea Csak
Journal:  Dig Dis Sci       Date:  2016-01-14       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.